trial
as of 2026-07-01Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
NCTId NCT01160991
at a glance
— · Completed
Enrollment 10 (actual)
Sponsored by Central Institute of Mental Health, Mannheim
Primary completion 2006-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
10 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2004-05
Primary completion
2006-10
Eligibility
MALE · 18 Years · 65 Years
Interventions & indications
Sponsors
Central Institute of Mental Health, MannheimLead Sponsor
SanofiCollaborator
Investigators
1
Daniel H. Mathalon, Ph.D., M.D.Principal Investigator
Sites
1 total
Mannheim, Germany
Facts & assertions
4 sourced
Enrollment
10
Phase
NA
Primary Completion Date
2006-10
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
investigator